GNH USA

Europe — EMA

Olanzapine Accord Healthcare Ireland

GNH USA supplies Olanzapine Accord Healthcare Ireland (Olanzapine), an atypical antipsychotic for schizophrenia and bipolar disorder. Contact for supply.

Olanzapine

Request sourcing

1
Pack/s

What is Olanzapine?

Olanzapine, the active ingredient in Olanzapine Accord Healthcare Ireland, is an atypical antipsychotic presented as oral tablets for oral use. It is indicated for the treatment of schizophrenia and bipolar disorder in adult patients. GNH USA supplies Olanzapine Accord Healthcare Ireland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olanzapine used for?

Olanzapine is an atypical antipsychotic used in the management of several psychiatric disorders.

- Schizophrenia: Reduces positive and negative symptoms and helps prevent relapse. - Bipolar I disorder (manic episodes): Controls acute mania and stabilises mood. - Maintenance treatment of schizophrenia: Supports long‑term symptom control and reduces hospitalisation risk.

What are the side effects of Olanzapine?

Olanzapine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Weight gain: increased appetite leading to body‑weight increase. - Sedation: drowsiness or feeling unusually sleepy. - Dry mouth: reduced salivary flow. - Constipation: slowed gastrointestinal motility. - Increased appetite: heightened desire for food. - Dizziness: light‑headed sensation, especially when standing.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: life‑threatening reaction with fever and muscle rigidity. - Agranulocytosis: severe reduction in white blood cells. - Hyperglycaemia/diabetes: marked elevation of blood glucose. - Tardive dyskinesia: involuntary, repetitive movements. - Myocarditis: inflammation of heart muscle. - Seizures: occurrence of convulsive episodes.

What precautions apply to Olanzapine?

When prescribing olanzapine, clinicians should consider several safety measures.

- Assess metabolic risk: monitor weight, glucose and lipid profiles regularly. - Evaluate cardiovascular status: check blood pressure and ECG when indicated. - Review psychiatric history: avoid abrupt discontinuation to prevent relapse. - Caution in elderly with dementia: increased mortality risk observed. - Pregnancy and lactation: use only if potential benefits outweigh risks. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

What does Olanzapine interact with?

Olanzapine can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - CYP1A2 inhibitors (e.g., fluvoxamine): may raise olanzapine plasma levels. - Strong CYP3A4 inducers (e.g., rifampicin): can reduce olanzapine exposure. - CNS depressants (e.g., benzodiazepines): increase sedation and respiratory depression risk. - QT‑prolonging agents (e.g., certain antiarrhythmics): may enhance cardiac arrhythmia potential.

Moderate Interactions (Monitor Closely): - Antihypertensives: additive orthostatic hypotension. - Antidiabetic drugs: olanzapine‑induced hyperglycaemia may require dose adjustment. - Lithium: heightened neurotoxicity risk. - Carbamazepine: moderate enzyme induction may lower olanzapine levels. - Smoking: induces CYP1A2, potentially decreasing drug concentration.

Frequently asked questions

What is Olanzapine Accord Healthcare Ireland used for?+
Olanzapine Accord Healthcare Ireland is an atypical antipsychotic indicated for the treatment of schizophrenia, the management of acute manic episodes in bipolar I disorder, and for long‑term maintenance therapy to reduce relapse risk in these conditions.
How does olanzapine work?+
Olanzapine works by blocking dopamine D2 and serotonin 5‑HT2A receptors while also affecting histamine, muscarinic and adrenergic receptors. This broad receptor antagonism helps to balance neurotransmitter activity in brain pathways that regulate mood, thought processes and perception.
What is the usual dose of olanzapine?+
The appropriate dose of olanzapine is determined individually by the prescribing clinician based on the patient’s diagnosis, severity of symptoms, prior treatment response and tolerability. Dosage adjustments are made according to clinical response and safety monitoring.
Is olanzapine safe during pregnancy or breastfeeding?+
Olanzapine should be used during pregnancy only if the potential benefit justifies any potential risk to the fetus. Limited data are available for breastfeeding, and the drug is excreted in breast milk; therefore, a risk‑benefit assessment is required before continuation while nursing.
How do I order Olanzapine Accord Healthcare Ireland from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does olanzapine compare with other antipsychotic drugs?+
Compared with first‑generation antipsychotics, olanzapine has a lower risk of extrapyramidal symptoms but a higher propensity for metabolic side effects such as weight gain and glucose elevation. Within the atypical class, its efficacy is comparable to risperidone and quetiapine, while its side‑effect profile differs in the degree of sedation and metabolic impact.
How should Olanzapine be stored and handled?+
Olanzapine tablets should be stored at ambient temperature, preferably below 25 °C, in the original blister pack or container to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.
How is Olanzapine administered?+
Olanzapine is administered orally as a tablet taken with or without food. The tablet should be swallowed whole with water and not chewed or crushed, unless a specific formulation permits alternative administration as directed by a healthcare professional.
What are the most serious risks associated with olanzapine?+
Serious risks include neuroleptic malignant syndrome, severe hyperglycaemia or new‑onset diabetes, agranulocytosis, tardive dyskinesia, and cardiovascular events such as myocarditis. Patients should be monitored regularly for signs of these conditions, and treatment should be discontinued promptly if they occur.
Who should not use olanzapine?+
Olanzapine is contraindicated in individuals with known hypersensitivity to the drug or any of its components. It should also be avoided in patients with severe central nervous system depression, uncontrolled narrow‑angle glaucoma, and in elderly patients with dementia‑related psychosis due to an increased risk of mortality.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Olanzapine
Route
Oral Use
Manufacturer
Accord Healthcare Ireland Limited
Origin
EU

Related products

Zyprexa 2.5 mg/1

Zyprexa 2.5 mg/1

Olanzapine · 2.5 mg

Zyprexa
TABLET
Eli Lilly and Company
USA
Zyprexa 5 mg/1

Zyprexa 5 mg/1

Olanzapine · 5 mg

Zyprexa
TABLET
Eli Lilly and Company
USA
Zyprexa 7.5 mg/1

Zyprexa 7.5 mg/1

Olanzapine · 7.5 mg

Zyprexa
TABLET
Eli Lilly and Company
USA
Zyprexa 10 mg/1

Zyprexa 10 mg/1

Olanzapine · 10 mg

Zyprexa
TABLET
Eli Lilly and Company
USA